Results 91 to 100 of about 21,764,403 (203)

A review of the inhibitory waste metabolites produced during mAb biomanufacturing

open access: yesBiotechnology Progress, EarlyView.
The review highlights inhibitory metabolites in CHO cell cultures, such as lactate, ammonia, isobutyrate, and isovalerate, impacting growth and productivity. Identification methods include LC/MS‐based metabolomics, while control strategies involve media optimization, genetic engineering, and process adjustments (pH, temperature).
Zhao Wang   +5 more
wiley   +1 more source

Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Domenico Nocera   +7 more
wiley   +1 more source

Review of CFD modelling techniques for single‐phase and multiphase flow in static mixers

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
This review synthesizes computational fluid dynamics (CFD) approaches for static mixers, linking hydrodynamics to pressure drop, particle/droplet distributions, mixing metrics, and heat‐transfer performance to guide modelling choices and design decisions. Abstract Static mixers enable compact and low‐energy intensification.
Jussan Jaeger   +7 more
wiley   +1 more source

Biowaiver as a Bioequivalence Study Option

open access: yesРегуляторные исследования и экспертиза лекарственных средств
SCIENTIFIC RELEVANCE. Biowaiver is a procedure for establishing the bioequivalence of generic and reference products without in vivo studies. Regulatory requirements for this procedure, as described in a variety of documents, differ in certain features ...
E. A. Volkova   +3 more
doaj   +1 more source

Evaluation and suggested improvements of the Biopharmaceutics Classification System (BCS)

open access: yesJournal of Pharmacy and Pharmacology, 2007
Abstract This review has evaluated the Biopharmaceutics Classification System (BCS) and improvements have been proposed. The BCS has a very strict solubility/dissolution limit, a generous Pe-limit (≥ 14-times higher rate constant limit for dissolution than for permeation), and is stricter for drugs with a long half-life (t1/2). Available
openaire   +2 more sources

BIOPHARMACEUTICS AND APPROACHES TO DRUG ABSORPTION ENHANCEMENT

open access: yes
Biopharmaceutics is a foundational discipline in pharmaceutical sciences that focuses on the interplay between drug physicochemical properties, formulation design, and physiological factors governing drug absorption and bioavailability.
Shradha. S. Mathpati   +4 more
core   +1 more source

Digital Transformation of Medicines Regulation in Africa—Perspectives from a Stakeholder Convening

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Regulatory authorities worldwide are developing strategies to integrate artificial intelligence (AI) into the lifecycle of health products, technologies, and medicines. While regulators share goals of improving efficiency, strengthening decision‐making, and protecting public health, their approaches differ according to institutional structures ...
Christelna Reyneke   +12 more
wiley   +1 more source

Preparation and Characterization of Dutasteride Nanoparticles as Oral Fast-Dissolving Film

open access: yesمجلة كلية الطب
Background: Dutasteride, is a drug whose mechanism of action is inhibition of the enzyme 5-alpha reductase. It has been approved for use in the treatment of benign prostatic hyperplasia.
Rusul W. Kadhum   +1 more
doaj   +1 more source

In Silico Prediction of Plasma Concentrations of Fluconazole Capsules with Different Dissolution Profiles and Bioequivalence Study Using Population Simulation

open access: yesPharmaceutics, 2019
A biowaiver is accepted by the Brazilian Health Surveillance Agency (ANVISA) for immediate-release solid oral products containing Biopharmaceutics Classification System (BCS) class I drugs showing rapid drug dissolution.
Marcelo Dutra Duque   +5 more
doaj   +1 more source

The EMA Qualification Opinion for CYP Inhibition‐Mediated Drug–Drug Interaction Predictions: Implications for PBPK Credibility Assessment in the Era of ICH M15

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Clinical pharmacology and pharmacometrics teams are now being encouraged to implement the ICH M15 framework in drug development to support model‐informed decisions in regulatory submissions. Although model performance is an important component of model evaluation, regulatory confidence also depends on the intended context of use (CoU) and the ...
Karen Rowland Yeo   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy